Immunoglobulin substitution in patients with secondary antibody deficiency in chronic lymphocytic leukemia and multiple myeloma: a representative analysis of guideline adherence and infections

INTRODUCTION: In secondary immunodeficiency, immunoglobulin replacement therapy (IgRT) is recommended by guidelines (GL) for patients with IgG level < 4 g/l and more than 3 infections or a severe infection. IgRT may be appropriate if IgG level < 4 g/l and/or 1–3 less severe infections (≤ grade...

Descripción completa

Detalles Bibliográficos
Autores principales: Link, Hartmut, Kerkmann, Markus, Holtmann, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046374/
https://www.ncbi.nlm.nih.gov/pubmed/35257229
http://dx.doi.org/10.1007/s00520-022-06920-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046374/
https://www.ncbi.nlm.nih.gov/pubmed/35257229
http://dx.doi.org/10.1007/s00520-022-06920-y

Ejemplares similares